Clicky

Nova Logo

An Evolution of Healing

An industry-leading biotechnology company, we specialize in developing and manufacturing advanced biomaterials for bone and soft tissue regeneration. With a relentless commitment to improving patient outcomes and revolutionizing the field of synthetic grafts, NovaBone products have emerged as a global visionary in developing innovative bone substitutes.

Offering the first Bioglass product to the medical community and leveraging the osteostimulative properties of 45S5 bioactive glass material, we not only foster bone tissue regeneration but also set a benchmark for future advancements in bone healing solutions.

A Legacy of Innovation: The Bioglass Journey

In the late 1960s, a groundbreaking discovery by Dr. Larry Hench transformed medical science. It all started at the University of Florida in Gainesville, mere miles from NovaBone's future offices. Dr. Hench's research on the biological application of glass had reached a breakthough, giving birth to 45S5 Bioglass. It was the first material of its kind to bond with living bone and stimulate bone regeneration. This remarkable invention not only paved the way for modern biomaterials but also set the foundation for the next generation of bone regeneration technologies.

At NovaBone, we are proud to continue this legacy of innovation. Our employee, Jipin Zhong, PhD, stands as a testament to our deep connection with 45S5 Bioglass' origins. Having studied directly under Dr. Larry Hench himself, Zhong embodies the bridge between foundational research and our cutting-edge applications in bone regeneration.

Our Commitment to Healing

Our products are designed with a deep understanding of the science of bone healing, leveraging the bioactive properties of Bioglass to support the body's natural healing processes. At NovaBone, we are not just creating products; we are crafting solutions that embody the spirit of innovation and commitment to improving patient outcomes.

Today, our company offers the broadest portfolio of regenerative grafting devices including bone formation products, as well as products that repair and remodel tissue. NovaBone’s bioactive bone graft devices have been used for over two decades in millions of clinical applications with unparalleled success validating the safety and efficacy of our technology.

Discover how our Bioglass-based products are setting new standards in regenerative medicine. With a foundation rooted in groundbreaking science and a future focused on innovation, NovaBone is at the forefront of healing technologies. Join us in shaping the future of bone regeneration.

NovaBone History

2002
2002
NovaBone Products, LLC was established with the purpose of developing differentiated synthetic biomaterials leveraging proprietary bioactive glass technology.
2005
2005
Received FDA clearance for the second-generation resorbable and bioactive synthetic particulate bone graft substitute.
2006
2006
Received FDA clearance for second-generation bioactive synthetic putty bone graft substitute and launched NovaBone Putty.
2009
2009
The Company broadened the bone graft portfolio and launched the morselized porous granules in vials & syringes.
2011
2011
Launched industry-first ortho and dental MIS cartridge putty delivery systems.
2012
2012
NovaBone expanded its R&D and manufacturing capabilities to widen its bone graft portfolio to collagen-based composite products.
2014
2014
Received FDA clearance for the first collagen bioactive glass composite products and launched NovaBone MacroFORM and Bioactive Strip.
2014
2014 Facility
NovaBone Products moved into a new 29,000 sq. ft. facility in Alachua, Florida significantly expanding its manufacturing capacity.
2015
2015
Received FDA clearance for dental collagen wound dressings and started manufacturing private-label wound dressings for various tier-one dental brands.
2017
2017
Received FDA clearance for the Irrigation Resistance Matrix product and launched two versions of the NovaBone IRM.
2020
2020
NovaBone joined forces with Halma PLC, a distinguished member of the FTSE 50 global group of life-saving technology companies.
2023
2023
Received FDA clearance for Wound Matrix. Under new leadership, NovaBone continues to positively impact lives. Launched the foot and ankle tapered syringe.
2024
2024
NovaBone launched precision tip for ortho MIS cartridge putty delivery system.
2025
2025
Launched industry-first synthetic pre-countoured Cotton & Evans wedges for foot and ankle osteotomies.
← Scroll horizontally to explore the timeline or click a year above to jump →

JOIN US IN
ADVANCING HEALING

Novabone white logo
NovaBone develops biomaterials that harness the body's natural healing process while meeting the specialized needs of dental and orthopedic surgeons.
Nova Ortho
Nova Dental

Important Links

Latest News

Contact Us